Weekly shot aims to curb cravings for both alcohol and food
NCT ID NCT07292519
Summary
This study is testing whether a weekly injection called Tirzepatide, when combined with a computer-based therapy program, can help adults who struggle with both heavy alcohol use and being overweight. Researchers want to see if this approach reduces the number of heavy drinking days and also improves weight and other health markers. The study will involve 46 participants who will receive either the real injection or a placebo (a look-alike with no drug) for 8 weeks, along with weekly therapy sessions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMORBIDITIES AND COEXISTING CONDITIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Drug Health Services, Royal Prince Alfred Hospital
Sydney, New South Wales, 2050, Australia
Contact Phone: •••-•••-••••
Contact Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.